Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Preclinical studies demonstrate antiinflammatory effects of selective PDE IV inhibitor

May 16, 1997

ABT-080 effective in animal model of lung eosinophilia

May 16, 1997

In vitro characterization of novel CysLTD1 receptor antagonist

May 16, 1997

Endothelin receptor blockade for airways inflammation

May 16, 1997

Airways-selective inhaled steroid for the treatment of asthma

May 16, 1997

Potent, selective, orally active tachykinin NK1 antagonist reported by Menarini

May 15, 1997

RPR and AMRAD initiate collaboration on antiasthmatic natural products

May 14, 1997

Dual H1/NK1 antagonist for allergic rhinitis from HMR

May 14, 1997

MMP inhibitor from British Biotech effective against oxidant-induced lung injury

May 14, 1997

Immunex reports new chemokine-binding protein

May 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...